Preclinical efficacy of MSLN-targeted P.21M CAR-T (PD1 antibody-IL21 fusion-secreting) against epithelial ovarian cancer

International Journal of Gynecological Cancer 2026

View at publisher

Authors: Zhiwen Xie, Lin Zhou, Haixi Liang, Chunyan Lan

DOI: 10.1016/j.ijgc.2025.103129

Cited by: 0

Fields of Study & Subjects

CAR-T cell therapy research Ovarian cancer diagnosis and treatment Immunotherapy and Immune Responses